Tandem Diabetes Care Inc at Robert W Baird Global Healthcare Conference Transcript
Good morning. Why don't we get started? My name is Jeff Johnson. I'm the Senior Medical Technology Analyst at Baird and our next presentation this morning is from Tandem Diabetes Care, the manufacturer, the t:slim Control-IQ insulin pump that has gained 25% to 30% share of the U.S. insulin pump market here in recent years. I think I'm right on that -- my math anyway. Yes, maybe more. I knew you were going to bristle at that point. With us today from Tandem we're happy to have Chief Executive Officer, John Sheridan; and Chief Financial Officer, Leigh Vosseller. John, I'll turn it over to you, and then we'll move into Q&A.
Well, thanks, Jeff. Good morning, everybody. I'll just start off by saying that when you look at diabetes and specifically Type 1 diabetes in the U.S., it's a large and underpenetrated market. Today there's about 1.8 million people with Type 1 in the U.S., about
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
